Skip to main content
Erschienen in: Endocrine Pathology 4/2012

01.12.2012

Pituitary Metastasis Presenting as Ischemic Pituitary Apoplexy Following Heparin-induced Thrombocytopenia

verfasst von: Ivan Kruljac, Vatroslav Čerina, Hrvoje Ivan Pećina, Leo Pažanin, Tomas Matić, Velimir Božikov, Milan Vrkljan

Erschienen in: Endocrine Pathology | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Pituitary apoplexy (PA) typically results from infarction or hemorrhage in a pituitary adenoma, while PA in nonadenomatous pituitary gland is uncommon. Prothrombotic states have never been recognized as precipitating factors for PA. The authors report a case of an elderly female who received prophylactic fractionated heparin therapy due to sepsis, consequent rhabdomyolysis, and overt disseminated intravascular coagulation. On the seventh day of heparin therapy, she reported sudden vision loss, ptosis, diplopia, and severe headache. Severe thrombocytopenia and positive antibodies to the complex of platelet factor 4 and heparin confirmed heparin-induced thrombocytopenia type 2 (HIT). Magnetic resonance imaging disclosed a homogenous pituitary tumor mass with pronounced sphenoid sinus mucosa thickening and two hypointense zones within the tumor mass on contrast-enhanced images consistent with focal ischemic necrosis. The tumor was confirmed to be squamous cell carcinoma with no signs of necrosis. Ischemic necrosis was found within marginal pituitary tissue. This is the first reported case of ischemic PA associated with pituitary metastasis and the first case in which HIT triggered PA. Our case demonstrates that prothrombotic states such as HIT can precipitate ischemic PA. Pituitary metastasis can present with ischemic PA, but radiological features differ from those described in pituitary adenomas. Segregated low-signal intensity zones within the tumor mass on postcontrast images indicate partial infarction of the tumor, which could be a special feature of ischemic PA in pituitary metastasis and has never been described in pituitary adenomas. These are all novel findings and might enlighten the pathogenesis of PA.
Literatur
1.
Zurück zum Zitat Semple PL, Webb MK, de Villiers JC, Laws ER, Jr. Pituitary apoplexy. Neurosurgery 56:65–72, 2005.PubMed Semple PL, Webb MK, de Villiers JC, Laws ER, Jr. Pituitary apoplexy. Neurosurgery 56:65–72, 2005.PubMed
2.
Zurück zum Zitat Sheehan HL. Postpartum necrosis of the pituitary. Journal of Pathology and Bacteriology 45:189–193, 1937.CrossRef Sheehan HL. Postpartum necrosis of the pituitary. Journal of Pathology and Bacteriology 45:189–193, 1937.CrossRef
3.
Zurück zum Zitat Arepally GM, Ortel TL. Clinical practice: heparin-induced thrombocytopenia. N Engl J Med 355:809–817, 2006.PubMedCrossRef Arepally GM, Ortel TL. Clinical practice: heparin-induced thrombocytopenia. N Engl J Med 355:809–817, 2006.PubMedCrossRef
4.
Zurück zum Zitat Morita A, Meyer FB, Laws ER Jr. Symptomatic pituitary metastases. J Neurosurg 89:69–73, 1998.PubMedCrossRef Morita A, Meyer FB, Laws ER Jr. Symptomatic pituitary metastases. J Neurosurg 89:69–73, 1998.PubMedCrossRef
5.
Zurück zum Zitat Furuta S, Hatakeyama T, Zenke K, Fukumoto S. Pituitary metastasis from carcinoma urinary bladder mimicking pituitary apoplexy—case report. Neurol Med Chir (Tokyo) 39:165–168, 1999.CrossRef Furuta S, Hatakeyama T, Zenke K, Fukumoto S. Pituitary metastasis from carcinoma urinary bladder mimicking pituitary apoplexy—case report. Neurol Med Chir (Tokyo) 39:165–168, 1999.CrossRef
6.
Zurück zum Zitat Lieschke GJ, Tress B, Chambers D. Endometrial adenocarcinoma presenting as pituitary apoplexy. Aust N Z J Med 20:81–84, 1990.PubMedCrossRef Lieschke GJ, Tress B, Chambers D. Endometrial adenocarcinoma presenting as pituitary apoplexy. Aust N Z J Med 20:81–84, 1990.PubMedCrossRef
7.
Zurück zum Zitat Biousse V, Newman NJ, Oyesiku NM. Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry 71:542–545, 2001.PubMedCrossRef Biousse V, Newman NJ, Oyesiku NM. Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry 71:542–545, 2001.PubMedCrossRef
8.
Zurück zum Zitat Maïza JC, Bennet A, Thorn-Kany M, Lagarrigue J, Caron P. Pituitary apoplexy and idiopathic thrombocytopenic purpura: a new case and review of the literature. Pituitary 7:189–92, 2004.PubMedCrossRef Maïza JC, Bennet A, Thorn-Kany M, Lagarrigue J, Caron P. Pituitary apoplexy and idiopathic thrombocytopenic purpura: a new case and review of the literature. Pituitary 7:189–92, 2004.PubMedCrossRef
9.
Zurück zum Zitat Willamowicz AS, Houlden RL. Pituitary apoplexy after anticoagulation for unstable angina. Endocr Pract 5:273–276, 1999.PubMed Willamowicz AS, Houlden RL. Pituitary apoplexy after anticoagulation for unstable angina. Endocr Pract 5:273–276, 1999.PubMed
10.
Zurück zum Zitat Smythe MA, Koerber JM, Mattson JC. The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital. Chest 131:1644–1649, 2007.PubMedCrossRef Smythe MA, Koerber JM, Mattson JC. The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital. Chest 131:1644–1649, 2007.PubMedCrossRef
11.
Zurück zum Zitat Kelton JG, Sheridan D, Santos A, et al. Heparin-induced thrombocytopenia: laboratory studies. Blood 72:925–930, 1988.PubMed Kelton JG, Sheridan D, Santos A, et al. Heparin-induced thrombocytopenia: laboratory studies. Blood 72:925–930, 1988.PubMed
12.
Zurück zum Zitat Semple PL, Jane JA, Lopes MB, Laws ER. Pituitary apoplexy: correlation between magnetic resonance imaging and histopathological results. J Neurosurg 108:909–915, 2008.PubMedCrossRef Semple PL, Jane JA, Lopes MB, Laws ER. Pituitary apoplexy: correlation between magnetic resonance imaging and histopathological results. J Neurosurg 108:909–915, 2008.PubMedCrossRef
13.
Zurück zum Zitat Ostrov SG, Quencer RM, Hoffman JC, Davis PC, Hasso AN, David NJ. Hemorrhage within pituitary adenomas: how often associated with pituitary apoplexy syndrome? AJR Am J Roentgenol 153:153–160, 1989.PubMed Ostrov SG, Quencer RM, Hoffman JC, Davis PC, Hasso AN, David NJ. Hemorrhage within pituitary adenomas: how often associated with pituitary apoplexy syndrome? AJR Am J Roentgenol 153:153–160, 1989.PubMed
14.
Zurück zum Zitat Arita K, Kurisu K, Tominaga A, Sugiyama K, Ikawa F, Yoshioka H, et al. Thickening of sphenoid sinus mucosa during the acute stage of pituitary apoplexy. J Neurosurg 95:897–901, 2001.PubMedCrossRef Arita K, Kurisu K, Tominaga A, Sugiyama K, Ikawa F, Yoshioka H, et al. Thickening of sphenoid sinus mucosa during the acute stage of pituitary apoplexy. J Neurosurg 95:897–901, 2001.PubMedCrossRef
Metadaten
Titel
Pituitary Metastasis Presenting as Ischemic Pituitary Apoplexy Following Heparin-induced Thrombocytopenia
verfasst von
Ivan Kruljac
Vatroslav Čerina
Hrvoje Ivan Pećina
Leo Pažanin
Tomas Matić
Velimir Božikov
Milan Vrkljan
Publikationsdatum
01.12.2012
Verlag
Springer US
Erschienen in
Endocrine Pathology / Ausgabe 4/2012
Print ISSN: 1046-3976
Elektronische ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-012-9224-9

Weitere Artikel der Ausgabe 4/2012

Endocrine Pathology 4/2012 Zur Ausgabe

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Thiopental Originalie

Als Folge des Urteils des Bundesverfassungsgerichts zur Sterbehilfe im Jahr 2020 wurde in den Jahren 2021–2023 eine Reihe (n = 23) von assistierten Suiziden im Landesinstitut für gerichtliche und soziale Medizin Berlin mit jeweils identischen …

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …